Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Neuroscience Letters|May 9, 2012
Targeted drug delivery to the peripheral nervous system using gene therapyDarren Wolfe, Marina Mata, David J Fink
Pain Medicine (Malden, Mass.)|October 13, 2009
A clinical trial of gene therapy for chronic painDarren Wolfe, James Wechuck, David Krisky, et al.
European Journal of Pain (London, England)|June 24, 2008
Effects of transgene-mediated endomorphin-2 in inflammatory painShuanglin Hao, Darren Wolfe, Joseph C Glorioso, et al.
Annals of Neurology|June 2, 2005
Gene transfer of glutamic acid decarboxylase reduces neuropathic painShuanglin Hao, Marina Mata, Darren Wolfe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic painShuanglin Hao, Marina Mata, Darren Wolfe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 2, 2005
Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous systemMunmun Chattopadhyay, Darren Wolfe, Marina Mata, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Delivery of herpes simplex virus-based vectors to the nervous systemJames R Goss, Atsushi Natsume, Darren Wolfe, et al.
Annals of Neurology|July 29, 2011
Gene therapy for pain: results of a phase I clinical trialDavid J Fink, James Wechuck, Marina Mata, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury painJun Liu, Darren Wolfe, Shuanglin Hao, et al.
Annals of Neurology|January 10, 2002
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3Munmun Chattopadhyay, Darren Wolfe, Shaohua Huang, et al.
Pageof 13